Skip to main content
. 2023 Sep 26;8(5):e1098. doi: 10.1097/PR9.0000000000001098

Table 2.

Multivariable analysis (estimates and P-values in brackets) for the entire patient cohort.

Parameters of sleep Sleep disturbance (R2 = 0.29) Sleep adequacy (R2 = 0.29) Sleep somnolence (R2 = 0.32) Sleep quantity (R2 = 0.14) DF
Diagnosis
 CRPS vs PHN 1.33 (0.180) −0.69 (0.531) −3.45 (<0.001) −0.12 (0.084) 2
 PDNP vs PHN 1.85 (0.150) −1.14 (0.426) 0.43 (0.695) −0.13 (0.150) 2
 CRPS vs PDNP −0.52 (0.690) 0.45 (0.759) −3.88 (<0.001) 0.01 (0.914) 2
Demographic/clinical data
 Sex (female vs male) 1.93 (0.017) −2.46 (0.006) −1.54 (0.024) −0.01 (0.867) 1
 Age 10-y estimate −0.78 (0.027) 2.78 (<0.001) 1.29 (<0.001) −0.02 (0.389) 1
 BMI 5-points estimate −0.28 (0.439) −0.53 (0.193) 1.67 (<0.001) −0.06 (0.023) 1
 Pain medication (no vs yes) −0.21 (0.828) 1.69 (0.118) −2.48 (0.003) 0.05 (0.468) 1
 Pain duration (≤3 vs > 3 y) −2.04 (0.050) 4.26 (<0.001) 0.22 (0.804) 0.24 (0.002) 1
 Pension request (yes vs no) −0.69 (0.478) 1.97 (0.069) 1.87 (0.024) 0.16 (0.021) 1
 Hospitalisation (no vs yes) −0.11 (0.901) 0.08 (0.932) −1.85 (0.013) −0.01 (0.911) 1
PD-Q symptoms
 Burning 0.85 (0.003) −0.94 (0.003) −0.34 (0.157) −0.05 (0.019) 1
 Prickling −0.13 (0.649) 0.30 (0.356) −0.33 (0.177) 0.03 (0.124) 1
 Allodynia 0.99 (0.001) −0.98 (0.004) 0.88 (<0.001) −0.08 (<0.001) 1
 Pain attacks 0.14 (0.569) −0.03 (0.928) 0.77 (<0.001) −0.01 (0.771) 1
 Thermal hyperalgesia 0.66 (0.019) −0.76 (0.015) 0.23 (0.338) −0.06 (0.004) 1
 Numbness 0.59 (0.023) −0.03 (0.912) 0.11 (0.630) −0.02 (0.376) 1
 Pressure-evoked pain 0.52 (0.097) 0.60 (0.085) −0.12 (0.658) 0.03 (0.193) 1
VAS
 Average pain 1.01 (<0.001) −1.08 (<0.001) −0.27 (0.267) −0.07 (<0.001) 1
 Maximum pain 0.10 (0.740) −0.18 (0.581) 1.06 (<0.001) −0.02 (0.346) 1
PHQ-9
 Depression 1.85 (<0.001) −2.11 (<0.001) 1.76 (<0.001) −0.07 (<0.001) 1

P-values in brackets. Significant values are shown as bold entries.

Parameters of sleep were assessed with Medical Outcome Study (MOS) Sleep Scale.

BMI, body mass index; average and maximum pain of the last 4 weeks assessed with VAS, visual analogue scale; CRPS, complex regional pain syndrome; PDNP, painful diabetic polyneuropathy; PD-Q, painDETECT questionnaire; PHN, postherpetic neuralgia; PHQ-9, Patient Health Questionnaire-9.